Drawing based on the description in the official product monograph. No photo yet.
“100 mg tablet: round, white film-coated tablet, printed with blue ink "BLU" on one side and "100" on the other side”
BLU 100 pill
Pill with imprint BLU 100 is white, round and has been identified as Avapritinib 100 mg. It is used for gastrointestinal stromal tumors. It is supplied by Blueprint Medicines Corporation.
Sold in Canada
Avapritinib 100 mg
- Brand
- Ayvakyt
- Imprint
- BLU 100
- Strength
- 100 mg
- Used for
- Gastrointestinal stromal tumors
- Color
- White
- Shape
- Round
- Form
- Tablet
- Manufacturer
- Blueprint Medicines Corporation
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02551780
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Avapritinib used for?
Avapritinib is used for gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
PDGFRA Exon 18 Mutation-Positive Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
AYVAKIT® is indicated for the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
Advanced Systemic Mastocytosis (AdvSM)
AYVAKIT is indicated for the treatment of adult patients with advanced systemic mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).
Limitations of Use:
AYVAKIT is not recommended for the treatment of patients with AdvSM with platelet counts of less than 50 × 109/L.
Indolent Systemic Mastocytosis (ISM)
AYVAKIT is indicated for the treatment of adult patients with indolent systemic mastocytosis (ISM).
Limitations of Use:
AYVAKIT is not recommended for the treatment of patients with ISM with platelet counts of less than 50 × 109/L.
From the FDA-approved label on DailyMed (published Sep 18, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows BLU 100. The parts can be split between the two sides, so turn the pill over and check both.
- It is white, round.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Ayvakyt by Blueprint Medicines Corporation.
In Canada: prescription only.
Ingredients
Active: Avapritinib
Other pills with imprint BLU 100
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
0115 2790
Chloroquine Phosphate 250 mg
White, round, 10 mm
Used for rheumatoid arthritis and amoeba infection
-
AA 16
Desipramine 150 mg
White, round, 11 mm
Used for depression and ADHD
-
par 256 MINOXIDIL 2 1 2
Minoxidil 2.5 mg
White, round, 7 mm
Used for severe high blood pressure and hair loss
-
L1
Colchicine Tablets 0.5 Mg 0.5 mg
White, round, 6 mm
-
C 17
Aminocaproic Acid 500 mg
White, round, 13 mm
Used for hemorrhage
-
CN250
Chloroquine Phosphate 250 mg
White, round, 10 mm
Used for rheumatoid arthritis and amoeba infection
Other Avapritinib pills
- BLU 200 Avapritinib 200 mg White, capsule, 16 mm Used for gastrointestinal stromal tumors
- BLU 200 Avapritinib 200 mg White, capsule Used for gastrointestinal stromal tumors
- BLU 25 Avapritinib 25 mg White, round, 5 mm Used for gastrointestinal stromal tumors
- BLU 300 Avapritinib 300 mg White, capsule, 18 mm Used for gastrointestinal stromal tumors
- BLU 50 Avapritinib 50 mg White, round, 6 mm Used for gastrointestinal stromal tumors
- No picture yet DIN 02551764 Avapritinib 25 mg Ayvakyt, Tablet, sold in Canada Used for gastrointestinal stromal tumors
- No picture yet DIN 02551772 Avapritinib 50 mg Ayvakyt, Tablet, sold in Canada Used for gastrointestinal stromal tumors